Two FTSE 100 growth and dividend stars I’d own for the long term

These attractively-valued FTSE 100 (INDEXFTSE:UKX) stocks offer investors impressive growth and great shareholder returns.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

There are good reasons many famous investors look to buy businesses that enjoy high barriers to entry for competitors. After all, keeping out would-be rivals often brings premium pricing power, attractive margins and big shareholder returns.

This is absolutely the case with credit bureau Experian (LSE: EXPN). One of just a handful of big, globe-spanning credit bureaux, Experian earns operating margins of around 25%, kicks off prodigious cashflow and returns gobs of it to shareholders.

On the face of it, its dividend yield may look a bit miserly at 2%. However, dividends are only half of the story for the firm as it also spends essentially the same amount of cash on share buybacks. Indeed, in the three years through fiscal year 2017, Experian’s business generated some $3.1bn in free cashflow that primarily flowed directly to investors via $1.1bn in dividends and another $1.1bn in buybacks.

And on top of very healthy shareholder returns, Experian also offers quite impressive growth prospects. This is due mainly to two factors. The first is the nature of our economies, where credit is integral to life for individuals and businesses alike. With more and more data points to hoover up, analyse, and sell, Experian and its peers are finding more and more customers willing to shell out for increasingly accurate data.

The second means of growth is through expansion into new regions and the addition of related services. As far as geographic expansion goes, Experian’s main target has been Brazil, which is close to becoming its second biggest market by revenue with the region accounting for roughly 16% of sales in 2017.

And on top of solid mid-single-digit organic growth and pushing into new markets, Experian isn’t afraid to use its financial heft to buy up smaller companies and begin cross-selling these new services to its array of customers. This includes highly pertinent areas such as identity protection for consumers.

All together these helped boost Experian’s revenue by 8% year-on-year in Q3 with organic growth clocking in at 5%. With this level of growth, high levels of shareholder returns and non-cyclical nature, Experian looks like a great long-term buy to me even at its current valuation of 23 times 2018 earnings.

Insuring a bright future for investors 

Another FTSE 100 growth and dividend star I’ve got my eye on is insurer Prudential (LSE: PRU). The group has been growing its dividend payouts by an average of 11.5% annually over the past five years and at today’s share price it kicks off a healthy 2.4% yield.

On top of this decent-but-fast-growing dividend, the group’s share price has been steadily rising as the insurer expands its highly profitable business in the US and reaps the rewards of its high exposure to increasingly wealthy Asian economies.

In the first half of 2017, the group’s operating profits rose 5% in constant exchange rates as US life insurance profits jumped 7% and Asian operations grew new business profits by a whopping 18%.

With management considering getting rid of low-growth UK operations to focus on faster-growing North American and Asian markets, a healthy and rising dividend and an attractive valuation of 17.6 times earnings, I reckon Prudential could be a great holding for the long term.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has recommended Experian. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »